Tripharma SPRL
1.0 FTEThe score of Tripharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -19 % Headcount (avg FTE) -9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Tripharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 68,582 € | ||||
| Equity | −28,957 € | ||||
| Cash | 44,513 € | ||||
| EBITDA | 90,220 € | ||||
| Total assets | 266,344 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 18 Aug 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 15 Mar 2024
- Year ended 31 Dec 2021filed on 24 Jan 2023
Tripharma's financial analysis
- Solvency-10.9%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Tripharma
Tripharma's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0426.092.096
- VAT number
- BE0426092096
- Peppol
- Registered · 0208:0426092096 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 06 Jun 1984
- Registered office
- 1080 Molenbeek-Saint-Jean
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Tripharma (SPRL) has been based in Molenbeek-Saint-Jean since 1984, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 68,582 € and equity of −28,957 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -10.9%, below the median of its sector (37.8%).
Companies similar to Tripharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE LA Place Albert Retail sale of pharmaceutical products Forest · balance sheet 266,481 €
- Apotheek Donné Retail sale of pharmaceutical products Turnhout · balance sheet 268,167 €
- Pharm.Assy Retail sale of pharmaceutical products Wemmel · balance sheet 268,957 €
- Apoteek Brichau Retail sale of pharmaceutical products Halle · balance sheet 263,690 €
- Maxipharma Retail sale of pharmaceutical products Charleroi · balance sheet 269,211 €
- C.E Pharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 263,031 €
- De Baere OLV Retail sale of pharmaceutical products Roosdaal · balance sheet 269,784 €
- Atouphar Retail sale of pharmaceutical products Flémalle · balance sheet 260,410 €
Frequently asked questions about Tripharma
What is the revenue of Tripharma?
Tripharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Tripharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0426092096 for Tripharma, if the company is VAT-registered. Its company number (CBE) is 0426.092.096.
Where is the registered office of Tripharma?
According to the CBE register, the registered office of Tripharma is in 1080 Molenbeek-Saint-Jean.
What is the equity of Tripharma?
At the close of the 2025 financial year, the equity of Tripharma amounts to -28,957 €, a solvency of -10.9% of total assets.
How many people work at Tripharma?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Tripharma?
The register lists 1 active mandates at Tripharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Tripharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →